Autoimmune Diseases  >>  NovoLog (insulin aspart)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

9 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NovoLog (insulin aspart) / Novo Nordisk
NCT00095446: NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes

Completed
4
513
US
insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
03/05
03/05
NCT00365170: Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

Completed
4
419
Canada, Europe, RoW
human insulin, insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1
04/05
04/05
NCT00593255: Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes

Completed
4
220
RoW
soluble human insulin, insulin aspart, insulin NPH
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
04/05
04/05
MIXING, NCT00542620 / 2006-006715-77: Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial

Completed
4
25
Europe
insulin detemir, insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1
03/09
03/09
NCT00913497: The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children

Checkmark
Feb 2013 - Feb 2013: 
Completed
4
16
US
insulin glulisine, (Apidra®), insulin aspart, (NovoLog®)
Spectrum Health Hospitals, Helen DeVos Children's Hospital
Type 1 Diabetes Mellitus
01/12
01/12
NCT01526733: Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

Completed
4
25
US
Sham Injection, Recombinant human hyaluronidase PH20, rHuPH20, PH20, Hylenex, Insulin aspart, Novolog, Aspart, Insulin lispro, Humalog, Lispro
Halozyme Therapeutics
Type 1 Diabetes Mellitus
08/12
09/13
NCT01678235: Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus

Completed
4
64
Europe
Insulin glulisine, Apidra®, Insulin aspart, NovoRapid®
Medical University of Warsaw
Type 1 Diabetes Mellitus
09/12
09/12
CONSISTENT 1, NCT01848990: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

Completed
4
456
US
Commercial Hylenex® recombinant (hyaluronidase human injection), Formulation 1, Hylenex, Recombinant human hyaluronidase (rHuPH20), Precommercial Hylenex recombinant (hyaluronidase human injection), Formulation 2, rHuPH20, Insulin lispro, Humalog, Lispro, Insulin aspart, Novolog, Aspart, Insulin glulisine, Apidra, Glulisine
Halozyme Therapeutics
Type 1 Diabetes Mellitus
02/14
09/14
NCT01269047: Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

Completed
4
37
US
Pramlintide, Symlin, Exenatide, Byetta, Type 1 diabetes, Insulin, Novolog, Humalog, Levemir, Lantus
Albert Einstein College of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes
08/16
12/16

Download Options